Supplementary Materials

Supplementary Material for:

Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis

Yonghao Cao, Brittany A. Goods, Khadir Raddassi, Gerald T. Nepom, William W. Kwok, J. Christopher Love, David A. Hafler*

*Corresponding author. E-mail: david.hafler{at}

Published 13 May 2015, Sci. Transl. Med. 7, 287ra74 (2015)
DOI: 10.1126/scitranslmed.aaa8038

This PDF file includes:

  • Fig. S1. Schematic representation of amplified T cell library assay.
  • Fig. S2. Sorting strategy of each T cell subpopulation.
  • Fig. S3. PCA of functional phenotypes of myelin-reactive CD4+CCR6 T cells.
  • Fig. S4. Functional phenotypes of myelin-reactive CD4+ T cells.
  • Fig. S5. Representative tetramer staining and sorting strategy of each library were chosen for single-cell cloning and RNA sequencing.
  • Fig. S6. Specificity of myelin-reactive CD4+ T cells.
  • Fig. S7. Phenotypic analysis of myelin-specific single-cell clones.
  • Fig. S8. Cell proliferation of each well from MS patients and healthy controls chosen for RNA sequencing.
  • Fig. S9. Correlation of RNA-seq data across biological replicates.
  • Fig. S10. Differential expression analysis of myelin-reactive T cells in MS and healthy controls.
  • Fig. S11. Correlation scatterplots.
  • Fig. S12. Heat maps of selected enriched gene sets identified by GSEA in MS tetramer-positive samples.
  • Fig. S13. Histogram showing distribution of the number of times each gene appeared across all gene sets.
  • Fig. S14. Heat map of log2FPKM values for the 224-gene leading-edge set.
  • Fig. S15. Enriched canonical pathways and network analysis.
  • Fig. S16. Additional network analysis.
  • Table S1. Patients with MS and paired healthy subjects information.
  • Table S2. Myelin peptides and control peptides used in T cell library assays.
  • Table S3. Percent variance explained by each principal component.
  • Table S4. GSEA results (FDR < 0.25) for comparison of MS tetramer-positive to MS tetramer-negative.
  • Table S5. GSEA results (FDR < 0.25) for comparison of healthy control tetramerpositive to healthy control tetramer-negative.
  • Table S6. Curated gene signatures corresponding to Fig. 4C.
  • Table S7. Gene sets used for leading-edge analysis to define pathogenic gene signature.
  • Table S8. Summary of networks constructed by IPA from pathogenic signature.
  • References (51, 52)

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S9 (Microsoft Excel format). Raw data of T cell library assays.
  • Table S10 (Microsoft Excel format). Statistical summary of T cell library data.

[Download Tables S9 and S10]